0001325812-16-000078.txt : 20160203 0001325812-16-000078.hdr.sgml : 20160203 20160203173417 ACCESSION NUMBER: 0001325812-16-000078 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160201 FILED AS OF DATE: 20160203 DATE AS OF CHANGE: 20160203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALNYLAM PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001178670 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770602661 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (617) 551-8200 MAIL ADDRESS: STREET 1: 300 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: ALNYLAM PHARMACEUTICALS INC DATE OF NAME CHANGE: 20020724 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mason Michael CENTRAL INDEX KEY: 0001514291 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36407 FILM NUMBER: 161385986 MAIL ADDRESS: STREET 1: 300 3RD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2016-02-01 0 0001178670 ALNYLAM PHARMACEUTICALS, INC. ALNY 0001514291 Mason Michael 300 THIRD STREET CAMBRIDGE MA 02142 0 1 0 0 VP, Finance and Treasurer Performance Stock Option 2014 (right to buy) 96.45 2016-02-01 4 A 0 2750.0 0.0 A 2016-02-01 2024-12-17 Common Stock 2750 2750 D On December 17, 2014, the reporting person was granted a performance based stock option to purchase shares of ALNY Common Stock. One-third of the shares subject to the option will vest upon the achievement of each of three specific clinical development and regulatory events, as approved by our compensation committee. Effective February 1, 2016, the compensation committee of the Company determined the first performance criteria had been met and the option vested as to one-third of the shares. Michael P Mason 2016-02-03